⚕ GalenOps CRO console
← 701 (USA)

701-1294

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2013-03-24
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-19 (study day 57.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-19 (study day 57.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-03-22 (study day -2.0); relationship: NONE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-19 (study day 57.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-19 (study day 57.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate RASH ERYTHEMATOUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-10 (study day 79.0); relationship: PROBABLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.